Moolec Science (MLEC) Free Cash Flow (2022 - 2024)
Moolec Science (MLEC) reported Free Cash Flow of $1.9 million for Q4 2024, down 13.22% on a YoY basis from $2.2 million in Q1 2024, and up 280.89% sequentially from -$1.1 million in Q3 2024.
Moolec Science (MLEC) Free Cash Flow (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Free Cash Flow data on file, last reported at $1.9 million in Q4 2024.
- For the quarter ending Q4 2024, Free Cash Flow fell 13.22% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (changed N/A YoY), and the FY2025 full-year result was -$2.0 million, down 106.8% from the prior year.
- Free Cash Flow rose to $1.9 million in Q4 2024, from -$1.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $37.8 million in Q2 2024 to a low of -$47.8 million in Q2 2023.
- A 3-year average of -$1.4 million and a median of -$600786.5 in 2022 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 475.06% in 2023, while the deepest fall reached 17089.24% in 2023.
- Tracing MLEC's Free Cash Flow over 3 years: stood at -$592663.0 in 2022, then surged by 475.06% to $2.2 million in 2023, then slipped by 13.22% to $1.9 million in 2024.
- Business Quant data shows MLEC's Free Cash Flow at $1.9 million in Q4 2024, -$1.1 million in Q3 2024, and $37.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | 37.78 Mn |
| Jun 30, 2024 | 37.78 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Dec 31, 2022 | -592,663.00 |
| Dec 31, 2022 | -592,663.00 |
| Sep 30, 2022 | 9,648.00 |
| Sep 30, 2022 | 9,648.00 |